HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

NCT06520540 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Glucagon-Like Peptide-1 Receptor Agonists

Interventions

DRUG: HDM1002 100 mg QD 12weeks
DRUG: HDM1002 200 mg QD 12weeks
DRUG: HDM1002 400 mg QD 12weeks，Q 2W for titration
DRUG: HDM1002 400 mg QD 12weeks，Q 3W for titration
DEVICE: Placebo

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.